The ROE (Return on Equity) of CStone Pharmaceuticals (2616.HK) is -25.07%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | -25.07% |
| 2023-12-31 | -80.39% |
| 2022-12-31 | -200.90% |
| 2021-12-31 | -159.08% |
| 2020-12-31 | -41.33% |
| 2019-12-31 | -93.02% |
| 2018-12-31 | -338.67% |
| 2017-12-31 | -72.46% |
| 2016-12-31 | -34.53% |